News & Events
US FDA Grants Pharmaxis' Bronchitol Orphan Drug Status
23 / 02 / 2005
Pharmaxis (ASX:PXS) announced today that the United States Food and Drug Administration (FDA) has granted an Orphan Drug status for the company's product BronchitolT, for the treatment of bronchiectasis. Orphan drug status has been granted to Pharmaxis on the basis of…
Displaying records 51-51 of 51